Covid-19 triggers research culture in Ayurveda, traditional medicines

Of 203 trials registered with the Clinical Trial Registry, 61.5% are from Ayush disciplines

GN Bureau | September 30, 2020


#Covid-19   #Novel Coronavirus   #healthcare   #Ayush ministry   #Ayurveda   #Yoga  
(Illustration: Ashish Asthana)
(Illustration: Ashish Asthana)

The Covid-19 pandemic has brought the spotlight on the health-promotive and disease-preventive solutions of Ayush (Ayurveda, Yoga, Unani, Siddha, Homeopathy) disciplines. What has not come into the limelight is the emerging nationwide trend in the Ayush disciplines, of taking up evidence-based studies.

A study made a thorough search of the Clinical Trial Registry of India for the registered trials of Covid-19 involving ayurveda intervention from March 1 to June 25, without language restrictions. The number of new trials registered in Ayurveda during this period was seen to be 58, the Ayush ministry said in a release on Wednesday.

News reports in August had revealed that out of the 203 trials registered in Clinical Trial Registry of India (CTRI), 61.5% were from Ayush disciplines. A recent study published in the ‘Journal of Research in Ayurvedic Sciences’ titled “Ayurveda Research Studies on Covid-19 Registered in CTRI: A critical appraisal” throws more light on this growing “research-culture” in Ayush disciplines.

Here is some additional insight into these CTRI registered trials involving Ayurveda and Covid-19. Approximately 70% of the total trials registered were sponsored by the government and various stakeholders of Ayurveda associated with the Ayush ministry. These trials will provide useful information to the researchers which will help them to strategize the next course of action and also help the general public for understanding the contribution of Ayurveda in Covid-19.

Once completed, the results of these promising studies will expectedly be published at the earliest so that it will be useful for the policymakers from the Ayush systems of medicines to strategize effective solutions to benefit public health initiatives. Further, in these challenging times, they will provide information for the global scientific community to know about the outcomes of Ayurveda clinical trials being conducted on Covid-19 in India. They will form potential source of information for further collaborative studies at the national and global levels.

Out of the 58 registered trials, 52 (89.66%) are interventional trials and 6 (10.34%) are observational trials. The majority of the trials included adult participants of both the gender as the target population. A total of 53 (91.38%) trials intend to recruit participants aged 18 years or more, and only 05 (8.62%) trials intended to recruit participants younger than 18 years.

The instant paper, which is authored by researchers of the Central Council for Research in Ayurvedic Sciences, provides detailed information about Ayurveda based Covid-19 clinical trials with respect to administrative information on trial registry number and sponsorship, descriptive information on study type and length of study and study design. Further, it tracks information related to the registration date and actual study start date and information related to recruitment, and all these have been collated, presented, and analysed based on the trails’ information registered between March 1 and June 25 in the CTRI.

With an increasing number of registered trials in this field, the body of knowledge in Ayush disciplines will increasingly reflect more contemporary information. This trend of evidence-based studies in the Ayush sector holds considerable promise for the public health activities in the country, as the studies may lead to cost-effective solutions that could be deployed on a nationwide scale.

Comments

 

Other News

"TV not in business of news; it is in the business of polarisation”

Television news these days has a loose relationship with truth, says senior journalist, columnist and author Vir Sanghvi, adding that it is not telling the truth and polarising opinions. In a live webcast with Kailashnath Adhikari, MD, Governance Now, during the Visionary Talk series held by

How the colonial rulers combated “this insidious and growing danger” of dust and smoke

Dust and Smoke: Air Pollution and Colonial Urbanism: India, c. 1860-1940 By Awadhendra Sharan Orient BlackSwan, xxiv+320 pages, Rs 795 Air pollu

Unlocking the value of renewable energy assets through InVITs in India

India has been witnessing a sluggish demand growth for power amidst COVID-19. It has affected both thermal as well as renewable energy (RE) sector. While thermal sector (coal) plant load factor (PLF) is coming down continuously amidst no new generation building up, renewable energy held its ground through

“Proposed power amendments anti- people, favor licensees”

Maharashtra Veej Grahak Sanghatana, a state-level coordination committee of industrial associations and power consumers, has approached the state government for urgent intervention on key concerns after Maharashtra Electricity Regulatory Commission on December 9 published the draft of the MERC (Electricity

Uddhav inaugurates largest tunnel boring machine for Mumbai Coastal Road

Maharashtra chief minister Uddhav Thackeray has launched the largest tunnel boring machine (TBM) for the Mumbai Coastal Road project at Priyadarshini Park, in Malabar Hill area of South Mumbai. Called Mavala, the TBM having the largest diameter and the first of its size to be used in the cou

Beyond open defecation: Tackling solid waste management issues

Antony Waste Handling Cell (AWHC) has been offering its services in handling municipal solid waste (MSW) across India for the past 19 years. When AWHC made its initial public offer (IPO) during December 21-23, it was subscribed 15 times. Why the sudden interest in this IPO? Did the market rightly and exped

Visionary Talk with Vir Sanghvi On the future of News Journalism





Archives

Current Issue

Opinion

Facebook    Twitter    Google Plus    Linkedin    Subscribe Newsletter

Twitter